Insights On Drug Development

  1. Nasal Delivery: Strategies For Success 3/2/2026

    A strengthened partnership enhances manufacturing for an ultra‑rare disease therapy, leveraging advanced containment upgrades to improve safety, reliability, capacity, and maintain global patient access.

  2. Re-Thinking ASD Development: When Your Molecule Breaks The Rules 2/26/2026

    A solvent‑free, fusion‑based approach streamlines amorphous solid dispersion development, enabling rapid early screening, improved performance, and sustainable manufacturing.

  3. From Molecule To Milestone: Fast Track Formulation 2/26/2026

    Fast‑track, data‑driven formulation strategies align early decisions with long‑term goals, enabling First‑in‑Human progress while reducing risk, avoiding rework, and supporting manufacturable development.

  4. Converting From A Spray-Dried Dispersion To A KinetiSol Formulation In <5 Months 2/26/2026

    A development team quickly turned a low‑bioavailability, high‑burden formulation into a streamlined, clinically improved version, boosting exposure, simplifying manufacturing, and accelerating progress.

  5. How The Accelerator™ Drug Development Model Enhances eNPV 2/25/2026

    Discover how an integrated CDMO and CRO model can accelerate development timelines, add up to $62.9 million in value, and help you maximize long-term pipeline success with a single, streamlined partner.

  6. Concept To Market: Scaling And Manufacturing Semi-Solid Topical Drugs 2/23/2026

    Learn how formulation, processing, and scale‑up choices impact the stability, structure, and performance of semi‑solid topicals while ensuring consistent quality through development.

  7. How Confident Are You In Your Autoinjector? 2/23/2026

    As demand for self-administered therapies accelerates, autoinjectors, formally known as automated needle-based injection systems (NIS-AUTO), are playing an increasingly central role in modern medicine. 

  8. A Patented Process For Intermediates Useful For Upadacitinib 2/18/2026

    Discover how innovative and safer synthetic strategies can streamline the manufacture of Upadacitinib while addressing the complexity and safety challenges inherent in its key intermediates.

  9. Corticosteroids And Hormonal Therapies — History, Use, And Future Outlook 2/18/2026

    Explore how evolving science, expanding global demand, and next-generation innovations are reshaping the future of corticosteroid and hormonal therapies — and what this transformation means for the years ahead.

  10. Redefining OSD Development Through Foresight And Innovation 2/12/2026

    From early formulation challenges to scale-up and commercial readiness, proactive planning and integrated capabilities help teams anticipate risks, accelerate decision-making, and maintain momentum across development.